Initumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Initumab, covering 2025-03-10 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles [Phase 4]